GlycoEra’s Series B Cash Will Fund Efforts To Take On FcRn Inhibitor Class

 
• By Joseph Haas
venture capital funding. green papaka, text on page wooden background.
GlycoEra raises a $130 series B round • Source: Shutterstock

More from Financing

More from Therapy Areas